Biodegradable Intraocular Therapies for Retinal Disorders: Progress to Date

ISSN： 1170-229X

Source： Drugs & Aging, Vol.27, Iss.2, 2010-02, pp. : 117-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fully Biodegradable Coronary Stents: Progress to Date

By Ramcharitar Steve Serruys Patrick W.

American Journal of Cardiovascular Drugs, Vol. 8, Iss. 5, 2008-01 ,pp. : 305-314

Adis International

Access to resources Recommend Favorite

Epigenetic-Based Therapies in Cancer: Progress to Date

By Song Sang-Hyun Han Sae-Won Bang Yung-Jue

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2391-2403

Adis International

Access to resources Recommend Favorite

Molecularly Targeted Therapies for Pediatric Acute Myeloid Leukemia: Progress to Date

By Brown Patrick Smith Franklin O.

Pediatric Drugs, Vol. 10, Iss. 2, 2008-01 ,pp. : 85-92

Adis International

Access to resources Recommend Favorite

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders: Progress to Date

By Reiss Allison B.

Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. : 2111-2120

Adis International

Access to resources Recommend Favorite

HIV Vaccines: Progress to Date

By > Andersen Christopher R. Kelleher Anthony D.

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 387-414

Adis International

Access to resources Recommend Favorite